Skip to main content

Table 1 ACE genotype and allele distributions among controls and migraine patients in different studies

From: Angiotensin-converting enzyme gene insertion/deletion polymorphism in migraine patients

   Genotypes Alleles
  N DD(%) ID(%) II(%) D(%) I(%)
Controls       
   Tronvik 403 92 (26.6) 204 (50.6) 107 (22.8) 388 (48.1) 418 (51.9)
   Paterna (ref 8) 201 75 (37.3) 101 (50.3) 25 (12.4) 251 (62.4) 151 (37.6)
   Lea (ref 9) 244 76 (31.1) 122 (50.0) 46 (18.9) 274 (56.1) 214 (43.9)
   Kowa (ref 10) 248 31 (12.5) 114 (46.0) 103 (41.5) 176 (35.5) 320 (64.5)
Migraine       
   Tronvik 347 78 (22.5) 186 (53.6) 83 (23.9) 342 (49.3) 352 (50.7)
   Paterna 302 146 (48.3) 129 (42.7) 27 (9.0) 421 (69.7) 183 (30.3)
   Lea 250 77 (30.8) 142 (56.8) 31 (12.4) 296 (59.2) 204 (40.8)
   Kowa 176 33 (18.7) 86 (48.9) 57 (32.4) 152 (43.2) 200 (56.8)
MwA subgroup       
   Tronvik 155 34 (21.9) 87 (56.1) 34 (21.9) 155 (50.0) 155 (50.0)
   Paterna NA NA NA NA NA NA
   Lea 151 48 (31.8) 85 (56.3) 18 (11.9) 181 (59.9) 121 (40.1)
   Kowa 54 14 (25.9)* 26 (48.2) 14 (25.9) 54 (50.0)* 54 (50.0)
MoA subgroup       
   Tronvik 187 43 (23.0) 96 (51.3) 48 (25.7) 182 (48.7) 192 (51.3)
   Paterna 302 146 (48.3)* 129 (42.7) 27 (9.0) 421 (69.7) 183 (30.3)
   Lea 99 29 (29.3) 57 (57.6) 13 (13.1) 115 (58.1) 83 (41.9)
   Kowa 122 19 (15.6) 60 (49.2) 43 (35.2) 98 (35.2) 146 (59.8)
  1. * Reported significant finding for genotype or allele frequencies